Cardiomyocyte deoxyribonucleic acid damage and cardiac recovery in paediatric dilated cardiomyopathy
European Journal of Cardio-Thoracic Surgery · 2023
DOI: 10.1093/ejcts/ezad064 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Yuji Tominaga und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathy, Dilated, Heart-Assist Devices, Heart Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES The goal of this study was to identify the clinical significance of the deoxyribonucleic acid (DNA) damage response marker, phosphorylated H2A histone variant X, on the bridge to recovery in low-weight paediatric patients with dilated cardiomyopathy (DCM) after having a Berlin Heart EXCOR implanted. METHODS Consecutive paediatric patients with DCM who had an EXCOR implanted for DCM at our hospital between 2013 and 2021 were reviewed. Patients were classified into 2 groups according to the degree of DNA damage in the left ventricular cardiomyocytes—the low DNA damage group and the high DNA damage group—using the median value as the threshold. We examined and compared the preoperative factors and histologic findings associated with cardiac functional recovery following the explant procedure in the 2 groups. RESULTS Competing outcome analysis of 18 patients (median body weight, 6.1 kg) showed that the incidence of an EXCOR explant was 40% at 1 year after the implant procedure. Serial echocardiography revealed significant left ventricular functional recovery in the low DNA damage group 3 months after the implant. The univariable Cox proportional hazards model revealed that the percentage of phosphorylated H2A histone variant X-positive cardiomyocytes was the significant factor associated with cardiac recovery and the EXCOR explant (hazard ratio, 0.16; 95% confidence interval, 0.027–0.51; P = 0.0096). CONCLUSIONS The degree of DNA damage response to the EXCOR implant may aid in predicting the bridge to recovery with EXCOR among low-weight paediatric patients with DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Pediatric Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
- Department of Pediatrics, Pediatric Cardiology, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Public Health, Osaka University Graduate School of Medicine, Osaka, Japan.
ORCID-Profile: Yuji Tominaga, Takuji Watanabe
Zitieren
APA
Tominaga, Y., Taira, M., Watanabe, T., Kugo, Y., Hasegawa, M., Narita, J., Ishida, H., Sakaniwa, R., Ueno, T., & Miyagawa, S. (2023). Cardiomyocyte deoxyribonucleic acid damage and cardiac recovery in paediatric dilated cardiomyopathy. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad064
Vancouver
Tominaga Y, Taira M, Watanabe T, Kugo Y, Hasegawa M, Narita J, et al. Cardiomyocyte deoxyribonucleic acid damage and cardiac recovery in paediatric dilated cardiomyopathy. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad064
BibTeX
@article{Tominaga2023,
author = {Tominaga, Yuji and Taira, Masaki and Watanabe, Takuji and Kugo, Yosuke and Hasegawa, Moyu and Narita, Jun and Ishida, Hidekazu and Sakaniwa, Ryoto and Ueno, Takayoshi and Miyagawa, Shigeru},
title = {Cardiomyocyte deoxyribonucleic acid damage and cardiac recovery in paediatric dilated cardiomyopathy},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
doi = {10.1093/ejcts/ezad064}
}
EUVIMED